THANH TRAN: Open Payments
NPI 1295107043 · CLAYTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,226 in 149 payments from 23 companies in 2025. Trend: 2023 $321 · 2024 $2,514 · 2025 $3,226
Food & beverage: $3,226
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $698 |
| Ardelyx, Inc. | 16 | $421 |
| Phathom Pharmaceuticals, Inc. | 17 | $238 |
| Lilly USA, LLC | 11 | $234 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $233 |
| Celltrion USA Inc. | 5 | $176 |
| Boston Scientific Corporation | 2 | $170 |
| Madrigal Pharmaceuticals | 6 | $165 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $159 |
| Gilead Sciences, Inc. | 5 | $124 |
Products named: IBSRELA, LINZESS, VOQUEZNA, OMVOH, RINVOQ, VEGZELMA, General - Polypectomy, REZDIFFRA.
Industry payments across NC — which companies pay providers there.
